Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Overexpression of Sp1 leads to p53-dependent apoptosis in cancer cells.

Chuang JY, Wu CH, Lai MD, Chang WC, Hung JJ.

Int J Cancer. 2009 Nov 1;125(9):2066-76. doi: 10.1002/ijc.24563.

2.

Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells.

Chintharlapalli S, Papineni S, Abdelrahim M, Abudayyeh A, Jutooru I, Chadalapaka G, Wu F, Mertens-Talcott S, Vanderlaag K, Cho SD, Smith R 3rd, Safe S.

Int J Cancer. 2009 Oct 15;125(8):1965-74. doi: 10.1002/ijc.24530.

3.

Reactive oxygen species are not required for an arsenic trioxide-induced antioxidant response or apoptosis.

Morales AA, Gutman D, Cejas PJ, Lee KP, Boise LH.

J Biol Chem. 2009 May 8;284(19):12886-95. doi: 10.1074/jbc.M806546200. Epub 2009 Mar 11.

4.

Arsenic-stimulated liver sinusoidal capillarization in mice requires NADPH oxidase-generated superoxide.

Straub AC, Clark KA, Ross MA, Chandra AG, Li S, Gao X, Pagano PJ, Stolz DB, Barchowsky A.

J Clin Invest. 2008 Dec;118(12):3980-9. doi: 10.1172/JCI35092. Epub 2008 Nov 13.

5.

Arsenic trioxide enhances the therapeutic efficacy of radiation treatment of oral squamous carcinoma while protecting bone.

Kumar P, Gao Q, Ning Y, Wang Z, Krebsbach PH, Polverini PJ.

Mol Cancer Ther. 2008 Jul;7(7):2060-9. doi: 10.1158/1535-7163.MCT-08-0287.

6.

Curcumin decreases specificity protein expression in bladder cancer cells.

Chadalapaka G, Jutooru I, Chintharlapalli S, Papineni S, Smith R 3rd, Li X, Safe S.

Cancer Res. 2008 Jul 1;68(13):5345-54. doi: 10.1158/0008-5472.CAN-07-6805.

7.

The role of p38 MAPK and JNK in Arsenic trioxide-induced mitochondrial cell death in human cervical cancer cells.

Kang YH, Lee SJ.

J Cell Physiol. 2008 Oct;217(1):23-33. doi: 10.1002/jcp.21470.

PMID:
18412143
8.
9.

Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide.

Lu J, Chew EH, Holmgren A.

Proc Natl Acad Sci U S A. 2007 Jul 24;104(30):12288-93. Epub 2007 Jul 18.

10.

Arsenical-based cancer drugs.

Dilda PJ, Hogg PJ.

Cancer Treat Rev. 2007 Oct;33(6):542-64. Epub 2007 Jul 10. Review.

PMID:
17624680
11.

Arsenic trioxide-mediated growth inhibition in gallbladder carcinoma cells via down-regulation of Cyclin D1 transcription mediated by Sp1 transcription factor.

Ai Z, Lu W, Ton S, Liu H, Sou T, Shen Z, Qin X.

Biochem Biophys Res Commun. 2007 Aug 31;360(3):684-9. Epub 2007 Jul 2.

PMID:
17617380
12.

Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors.

Chintharlapalli S, Papineni S, Ramaiah SK, Safe S.

Cancer Res. 2007 Mar 15;67(6):2816-23.

13.

Downregulation of transcription factor, Sp1, during cellular senescence.

Oh JE, Han JA, Hwang ES.

Biochem Biophys Res Commun. 2007 Feb 2;353(1):86-91. Epub 2006 Dec 4.

PMID:
17161377
14.
15.

Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin.

Jin HO, Yoon SI, Seo SK, Lee HC, Woo SH, Yoo DH, Lee SJ, Choe TB, An S, Kwon TJ, Kim JI, Park MJ, Hong SI, Park IC, Rhee CH.

Biochem Pharmacol. 2006 Nov 15;72(10):1228-36. Epub 2006 Sep 6.

PMID:
16950207
16.

Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation.

Abdelrahim M, Baker CH, Abbruzzese JL, Safe S.

J Natl Cancer Inst. 2006 Jun 21;98(12):855-68.

PMID:
16788159
17.

Arsenic derivatives in hematologic malignancies: a role beyond acute promyelocytic leukemia?

Verstovsek S, Giles F, Quintás-Cardama A, Perez N, Ravandi-Kashani F, Beran M, Freireich E, Kantarjian H.

Hematol Oncol. 2006 Dec;24(4):181-8. Review.

PMID:
16783836
18.
19.

Regulation of vascular endothelial growth factor receptor-2 expression in pancreatic cancer cells by Sp proteins.

Higgins KJ, Abdelrahim M, Liu S, Yoon K, Safe S.

Biochem Biophys Res Commun. 2006 Jun 23;345(1):292-301. Epub 2006 May 2.

PMID:
16678129
20.

Mitogen-activated protein kinases mediate arsenic-induced down-regulation of survivin in human lung adenocarcinoma cells.

Cheng Y, Chang LW, Tsou TC.

Arch Toxicol. 2006 Jun;80(6):310-8. Epub 2005 Nov 19.

PMID:
16328441

Supplemental Content

Support Center